Home > Insider Trading > Filing (0001661181-21-000054)

Filing Details

Accession Number:: 0001661181-21-000054
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-08 20:03:39
Reporting Period:: 2021-06-04

Accepted Time:: 2021-06-08 20:03:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1661181	Organogenesis Holdings Inc.	ORGO	Biological Products, (No Disgnostic Substances) (2836)	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1074084	Albert Erani	C/O A&Amp;E Stores, Inc. 1000 Huyler Street Teterboro NJ 07608		No	No	Yes	No
1760694	Starr Wisdom	44 Wilson Street Hartsdale NY 10530		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Disposition	2021-06-04	60,000	$16.22	59,776,745	No	4	S	Direct
Class A Common Stock	Disposition	2021-06-07	94,612	$16.14	59,682,133	No	4	S	Direct
Class A Common Stock	Disposition	2021-06-08	100,000	$15.41	59,582,133	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The reported securities sold were held directly by Albert Erani, who is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Albert Erani.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.11 to $16.30, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
Reflects the total number of securities held by the Group.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.49, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.19 to $16.05, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.